LORICRIN and Alzheimer disease: We also confirmed whether cASCs and cASC-EVs affect the expression levels of epidermal differentiation proteins, such as keratin1 (K1), filaggrin (FLG), loricrin (LOR), and involucrin (INV), to improve AD in dorsal skin lesions treated with DNCB.